1. Novel downstream molecular targets of SIRT1 in melanoma: A quantitative proteomics approach
   Chandra K. Singh et al, 2014, Oncotarget CrossRef
2. lncRNA CCAT1 is a biomarker for the proliferation and drug resistance of esophageal cancer via the miR‐143/PLK1/BUBR1 axis
   Min Hu et al, 2019, Molecular Carcinogenesis CrossRef
3. Mad2 and BubR1 modulates tumourigenesis and paclitaxel response in MKN45 gastric cancer cells
   J Bargiela-Iparraguirre et al, 2014, Cell Cycle CrossRef
4. BMP signaling pathways affect differently migration and invasion of esophageal squamous cancer cells
   Min Hu et al, 2017, International Journal of Oncology CrossRef
5. Immunohistochemical Expression of BubR1 and Telomerase in Minor Salivary Gland Tissue Adjacent to Oral Squamous Cell Carcinoma
   Marwa Hamied, 2021, Sulaimani Dental Journal CrossRef
6. Hmga1null mouse embryonic fibroblasts display downregulation of spindle assembly checkpoint gene expression associated to nuclear and karyotypic abnormalities
   Giovanna Maria Pierantoni et al, 2016, Cell Cycle CrossRef
7. Cell-cycle synchronization reverses Taxol resistance of human ovarian cancer cell lines
   Xueqing Wang et al, 2013, Cancer Cell International CrossRef
8. Mitotic slippage and the subsequent cell fates after inhibition of Aurora B during tubulin-binding agent–induced mitotic arrest
   Yasuo Tsuda et al, 2017, Scientific Reports CrossRef
9. Molecular mechanisms associated with chemoresistance in esophageal cancer
   Matheus Lohan-Codeço et al, 2022, Cellular and Molecular Life Sciences CrossRef